Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pulmozyme timing relative to physiotherapy in cystic fibrosis
ACTRN12611001041943Phase 4Completed
- Sponsor
- Jenny Bishop
- Start
- Jan 2000
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of dornase alfa in cystic fibrosis (CF) (2 arms), sponsored by Jenny Bishop. Primary endpoint: Change in lung function. Started Jan 2000; status: completed.
02
Drugs
dornase alfa
03
Conditions
cystic fibrosis (CF)
Beyond the preview
Go deeper on ACTRN12611001041943.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12611001041943.